Your browser doesn't support javascript.
loading
Reply to Ghosh et al1 . Comments on Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder.
Ahmad, Ateeq; Sheikh, Saifuddin; Khan, Mujtaba Ali; Chaturvedi, Alok; Patel, Piyush; Patel, Ronak; Buch, Bakul Chandrakant; Anand, Rajendra Someshwar; Shah, Timirkumar Chandrakant; Vora, Vaishal Nareshchandra; Ramasubramanian, Vikhram; Rao, Satyanarayana; Kumar, Narendra; Prasad, B S V; Sathianathan, Ramanathan; Verma, Kamal Kumar; Jhanwar, Venu Gopal; Kumar, Nand; Shah, Sandip; Dalal, Pronob Kumar; Sindhu, Brahmdeep; Talukdar, Payel; Ahmad, Imran.
Afiliación
  • Ahmad A; Jina Pharmaceuticals Inc., Libertyville, Illinois, USA.
  • Sheikh S; Jina Pharmaceuticals Inc., Libertyville, Illinois, USA.
  • Khan MA; Intas Pharmaceuticals Ltd., Ahmedabad, India.
  • Chaturvedi A; Intas Pharmaceuticals Ltd., Ahmedabad, India.
  • Patel P; Intas Pharmaceuticals Ltd., Ahmedabad, India.
  • Patel R; Lambda Therapeutic Research Ltd., Ahmedabad, India.
  • Buch BC; Shri Hatkesh Healthcare Foundation, Junagadh, India.
  • Anand RS; Kanoria Hospital and Research Centre, Bhat, Gandhinagar, India.
  • Shah TC; Divyam Hospital, Surat, India.
  • Vora VN; Ratandeep Multispecialty Hospital, Ahmedabad, India.
  • Ramasubramanian V; Ahana Hospitals, Madurai, India.
  • Rao S; JSS Medical College Hospital, Mysore, India.
  • Kumar N; Mysore Medical College and Research Institute, K.R. Hospital, Mysore, India.
  • Prasad BSV; Sujata Birla Hospital and Medical Research Center, Nasik, India.
  • Sathianathan R; Sri Ramachandra Medical College and Research Institute, Chennai, India.
  • Verma KK; S.P. Medical College and A.G. Hospitals, Bikaner, India.
  • Jhanwar VG; Deva Institute of Healthcare and Research, Varanasi, India.
  • Kumar N; All India Institute of Medical Sciences, New Delhi, India.
  • Shah S; Gujarat Medical Education & Research Society Medical College, Gotri, India.
  • Dalal PK; King George's Medical University, G.M. Associated Hospitals, Lucknow, India.
  • Sindhu B; Civil Hospital, Gurugram, India.
  • Talukdar P; Nil Ratan Sircar Medical College and Hospital, Kolkata, India.
  • Ahmad I; Jina Pharmaceuticals Inc., Libertyville, Illinois, USA.
Bipolar Disord ; 24(1): 91-92, 2022 02.
Article en En | MEDLINE | ID: mdl-34773320
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Bipolar Disord Asunto de la revista: PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Bipolar Disord Asunto de la revista: PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos